Charles River Laboratories (CRL)CEO bought ~$1M
James C Foster, CEO at Charles River Laboratories, bought ~$1M of Charles River Laboratories shares.
- ~$1M
- Approx. value · 6,075 sh @ $165.01
- 184K
- Holds after · shares reported
- Traded
- Feb 20, 2025
- Filed
- Feb 21, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 15, 2025CongressDisclosed purchase of CRL — reported range $1,001 - $15,000
- Feb 20, 2025 · this disclosureInsiderCEO purchased ~$1M of CRL shares in the open market
What came next
- Feb 20, 2025Insider · 2 peopleInsiders: 1 purchase (~$249K), 1 sale (~$715K)
- Apr 8, 2025CongressDisclosed purchase of CRL — reported range $15,001 - $50,000
- May 13, 2025InsiderOfficer sold ~$73K of CRL shares in the open market
- May 14, 2025Insider · 1 personInsiders: 5 sales (~$20K)
- May 15, 2025Insider · 1 personInsiders: 3 sales (~$19K)
- May 15, 2025CongressDisclosed sale of CRL — reported range $1,001 - $15,000
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Charles River Laboratories
For Charles River Laboratories, OQRO holds 19 insider filings (SEC Form 4 or Form 144), 11 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.
Other recent filings by James C Foster, Chairman, President and CEO
- SEC Form 4 at Charles River Laboratories (CRL)Aug 27, 2026
- SEC Form 4 at Charles River Laboratories (CRL)Aug 11, 2026
- SEC Form 4 at Charles River Laboratories (CRL)Jul 1, 2026
The full history of James C Foster, Chairman, President and CEO is on the profile page.
How this filing works
Other disclosures at Charles River Laboratories
- SEC Form 4Oct 8, 2026
- SEC Form 144Oct 5, 2026
- USAspending.gov award recordSep 28, 2026
- USAspending.gov award recordSep 25, 2026
- USAspending.gov award recordSep 17, 2026
- USAspending.gov award recordSep 17, 2026
Everything OQRO holds on this company is on its CRL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
